Alternatives to Lamin

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Clinical-stage AI drug discovery company running a wet-and-dry lab-in-the-loop engine with 2M weekly experiments and a 50+ PB phenomics dataset

Dotmatics Luma: agentic AI that plans, executes, and completes R&D data analysis, report generation and platform configuration for multimodal scientific

Exscientia now lives inside Recursion — an AI drug discovery engine built on automated wet labs and a 50+ PB dataset.

Open-source benchmark scoring AI reasoning on therapeutic decision-making, with a 2026 software-engineering edition.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.

Oncology real-world evidence platform turning patient data into AI-assisted cancer research insights.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

Tempus is an AI precision oncology platform that pairs tumor DNA/RNA sequencing with a 7M+ de-identified clinical record library for treatment and trial

AI-guided protein engineering that co-optimizes binding, stability, activity, and expression using your own wet-lab data.

Open-source multimodal lakehouse that keeps curation, feature engineering, hybrid search, and training on one Lance table.

Finster AI is an agentic finance platform that automates data synthesis, analysis, and PowerPoint-ready output for investment banking, asset management, and

Novaflow is an AI data analyst that turns raw biology data into publication-ready results without a terminal.

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

AI infrastructure that turns clinical data into publication-ready real-world evidence in minutes.

PicnicAI turns patient health records into clinical research data and real-world evidence.

AI and computational bionanotechnology R&D partnership that designs field-ready molecular diagnostics for emerging biological threats in days, not 12+ months.

Per-plant crop intelligence platform from Alphabet's X, now acquired by Driscoll's and John Deere

Owkin's K Pro is an autonomous AI scientist agent that informs biopharma R&D, clinical trial and portfolio decisions.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Silico is Goodfire's interpretability agent for understanding, debugging, and controlling the internals of your AI models

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease through partnership-led discovery.

Generative AI drug discovery suite covering target ID, molecule design, biologics engineering and clinical trial prediction.

Insight Booster automates enterprise-scale research, analysis, and report generation with agentic AI workflows.

All-in-human AI foundation models that predict brain activity and therapy response for CNS drug programs

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

AI Voice of the Customer analytics that turns unstructured customer feedback into measurable business outcomes

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based simulation plus AI for molecular discovery across drug and materials design.